P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
暂无分享，去创建一个
M. Kris | V. Rusch | I. Wistuba | D. Carbone | H. Pass | G. Patterson | P. Bunn | R. Doebele | D. Kwiatkowski | J. Chaft | E. Haura | R. Merritt | E. Garon | K. Reckamp | D. Finley | J. Lee | A. Nicholas | S. Phan | S. Waqar | E. Toloza | D. Raz | K. Schulze | J. Blasberg | C. Mcnamee | M. Nagasaka | F. Baciewicz | John D Mitchell | D. Owen | B. Johnson | A. Johnson